Skip to main content
OpenTrials

Clinical trial condition

TNBC

Explore clinical trials studying TNBC. Study availability and eligibility vary by location and protocol.

15 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

TNBC trial results

Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

NCT07017673

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Beverly Hills Los Angeles, California, United States
  • Huntington Cancer Center, an Affiliate of CS Cancer Pasadena, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT06682793

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Not Yet Recruiting

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

NCT07552181

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Beverly Hills Beverly Hills, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details

Related conditions